novo nordisk is cutting prices on its popular glp-1 drugs. cuts 70%, but semaglutide revenue could grow in 2026 Novo Nordisk slashing prices for
Description
Diabetes Obes Metab 23(9):21162124

New Engl J Med

They all refer to the same molecule, semaglutide

( Epub 20171030 )

Estimated Sustainable Cost-based Prices for Diabetes Medicines
